187 related articles for article (PubMed ID: 11708167)
1. Protease inhibitors: opium of the masses?
Martinez LJ
Res Initiat Treat Action; 2000 Sep; 6(3):7-11. PubMed ID: 11708167
[No Abstract] [Full Text] [Related]
2. New versions of antiretroviral guidelines contain some important changes.
Murphy MJ
Fac Notes (New Orleans La); 1999; 11(4):1-3. PubMed ID: 11810843
[No Abstract] [Full Text] [Related]
3. Antiretroviral rounds. Putting resistance to work.
Daar ES; Elion R
AIDS Clin Care; 2004 Jul; 16(7):56, 60. PubMed ID: 15300926
[No Abstract] [Full Text] [Related]
4. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
[No Abstract] [Full Text] [Related]
5. Another take on when to start and how to succeed.
Friedland GH
AIDS Clin Care; 2001 Sep; 13(9):82. PubMed ID: 11547600
[No Abstract] [Full Text] [Related]
6. Nonnucleoside reverse transcriptase inhibitors.
Murphy RL
AIDS Clin Care; 1997 Oct; 9(10):75-7, 79. PubMed ID: 11364757
[TBL] [Abstract][Full Text] [Related]
7. HIV: it's beginning to look like a chronic disease.
del Rio C
AIDS Clin Care; 2001 Sep; 13(9):82-3. PubMed ID: 11547601
[No Abstract] [Full Text] [Related]
8. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J
Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396
[TBL] [Abstract][Full Text] [Related]
9. Rescue regimens: the value of PI boosting.
Segal-Maurer S; Schütz M
Posit Aware; 2001; 12(6):35-7. PubMed ID: 11785478
[No Abstract] [Full Text] [Related]
10. Anti-HIV drug update.
Proj Inf Perspect; 2000 Aug; (30):5-6. PubMed ID: 12171015
[TBL] [Abstract][Full Text] [Related]
11. Rescue me.
Simmons P
Res Initiat Treat Action; 1998 Aug; 4(5):10. PubMed ID: 11365705
[TBL] [Abstract][Full Text] [Related]
12. Superiority of protease inhibitors over nonnucleoside reverse-transcriptase inhibitors when highly active antiretroviral therapy is resumed after treatment interruption.
Barreiro P; de Mendoza C; González-Lahoz J; Soriano V
Clin Infect Dis; 2005 Sep; 41(6):897-900. PubMed ID: 16107992
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
[TBL] [Abstract][Full Text] [Related]
14. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
Cardiello P; Srasuebkul P; Hassink E; Mahanontharit A; Samor T; Ruxrungtham K; Lange J; Cooper D; Phanuphak P
HIV Med; 2005 Mar; 6(2):122-8. PubMed ID: 15807718
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
16. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
17. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
Murphy RL
Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
[TBL] [Abstract][Full Text] [Related]
18. When to start therapy--and what to start with.
Gallant JE
Posit Aware; 1997; 8(1):22-3. PubMed ID: 11364093
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
[No Abstract] [Full Text] [Related]
20. Simply stated...on your mark, get set, go.
Res Initiat Treat Action; 1998 Jul; 4(4):15. PubMed ID: 11365644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
